Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001013762-25-004072
Filing Date
2025-03-28
Accepted
2025-03-28 16:05:24
Documents
104
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0235481-10k_immucell.htm   iXBRL 10-K 1364643
2 INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND MICHAEL F. BRIGHAM DATE ea023548101ex10-10_immucell.htm EX-10.10 17391
3 AMENDED AND RESTATED INCENTIVE COMPENSATION AND SEVERANCE AGREEMENT BETWEEN THE ea023548101ex10-11_immucell.htm EX-10.11 38938
4 INSIDER TRADING POLICY OF THE COMPANY ADOPTED AS OF DECEMBER 11, 2024 ea023548101ex19_immucell.htm EX-19 62331
5 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea023548101ex23-1_immucell.htm EX-23.1 2388
6 CERTIFICATION ea023548101ex31_immucell.htm EX-31 10530
7 CERTIFICATION ea023548101ex32_immucell.htm EX-32 4731
8 GRAPHIC image_001.jpg GRAPHIC 131262
9 GRAPHIC image_002.jpg GRAPHIC 127973
10 GRAPHIC image_003.jpg GRAPHIC 32108
  Complete submission text file 0001013762-25-004072.txt   8431119

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE iccc-20241231.xsd EX-101.SCH 60606
12 XBRL CALCULATION FILE iccc-20241231_cal.xml EX-101.CAL 55713
13 XBRL DEFINITION FILE iccc-20241231_def.xml EX-101.DEF 327765
14 XBRL LABEL FILE iccc-20241231_lab.xml EX-101.LAB 621923
15 XBRL PRESENTATION FILE iccc-20241231_pre.xml EX-101.PRE 362766
107 EXTRACTED XBRL INSTANCE DOCUMENT ea0235481-10k_immucell_htm.xml XML 870172
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12934 | Film No.: 25785916
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)